We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson's Disease.
- Authors
Gonzalez-Alcocer, Alfredo; Duarte-Jurado, Ana Patricia; Soto-Dominguez, Adolfo; Loera-Arias, Maria de Jesus; Villarreal-Silva, Eliud Enrique; Saucedo-Cardenas, Odila; de Oca-Luna, Roberto Montes; Garcia-Garcia, Aracely; Rodriguez-Rocha, Humberto
- Abstract
Biometals are all metal ions that are essential for all living organisms. About 40% of all enzymes with known structures require biometals to function correctly. The main target of damage by biometals is the central nervous system (CNS). Biometal dysregulation (metal deficiency or overload) is related to pathological processes. Chronic occupational and environmental exposure to biometals, including iron and copper, is related to an increased risk of developing Parkinson's disease (PD). Indeed, biometals have been shown to induce a dopaminergic neuronal loss in the substantia nigra. Although the etiology of PD is still unknown, oxidative stress dysregulation, mitochondrial dysfunction, and inhibition of both the ubiquitin–proteasome system (UPS) and autophagy are related to dopaminergic neuronal death. Herein, we addressed the involvement of redox-active biometals, iron, and copper, as oxidative stress and neuronal death inducers, as well as the current metal chelation-based therapy in PD.
- Subjects
PARKINSON'S disease; DOPAMINERGIC neurons; COPPER; METALS; SUBSTANTIA nigra; CENTRAL nervous system; IRON
- Publication
International Journal of Molecular Sciences, 2023, Vol 24, Issue 2, p1256
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms24021256